Millipore Sigma Vibrant Logo

524403 Pravastatin, Sodium Salt - CAS 81131-70-6 - Calbiochem

A water-soluble, competitive 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor that potently blocks in vivo cholesterol synthesis (Ki = ~1 nM).

Pravastatin, Sodium Salt - CAS 81131-70-6 - Calbiochem: のSDS（安全データシート）、CoA（試験成績書）およびCoQ（品質証明書）、カタログなど製品関連の技術資料を入手いただけます。

同義語: (βR,δR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-β,δ,6-trihydroxy-2-methyl-8[(2S)-2-methyl-1-oxobutoxyl]-1-naphthaleneheptanoic Acid Na, 3β-Hydroxycompactin, Na

Primary Target: AMG-CoA reductase
View This Product on Sigma-Aldrich
524403
価格＆在庫状況を照会

概要

Replacement Information

主要スペック表

CAS #Empirical Formula
81131-70-6C₂₃H₃₅O₇.Na

価格＆在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
524403-25MGCN
在庫状況検索中…
—
現在国内在庫なし 現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      		 Plastic Bag(s) 25 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示　
      値引
      ()
       
      —
      弊社照会
      		 —
      Description
      OverviewA water-soluble, competitive 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor that potently blocks in vivo cholesterol synthesis (Ki = ~1 nM). Offers cardioprotection. Also acts as an immunomodulator and an inhibitor of ras p21 isoprenylation.
      Catalogue Number524403
      Brand Family Calbiochem®
      Synonyms(βR,δR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-β,δ,6-trihydroxy-2-methyl-8[(2S)-2-methyl-1-oxobutoxyl]-1-naphthaleneheptanoic Acid Na, 3β-Hydroxycompactin, Na
      References
      ReferencesKwak, B., et al. 2000. Natl. Med. 6, 1399.
      Hamelin, B.A., and Turgeon, J., 1998. Trends Pharmacol. Sci. 19, 26.
      Narisawa, T., et al. 1996. Jpn. J. Cancer Res. 87, 798.
      Cohen, L.H., et al. 1993. Biochem. Pharmacol. 45, 2203.
      Koga, T., et al. 1990. Biochim. Biophys. Acta. 1045, 115.
      Yoshino, G., et al. 1986. Diabetes Res. Clin. Pract. 2, 179
      Product Information
      CAS number81131-70-6
      ATP CompetitiveN
      FormWhite crystalline solid
      Hill FormulaC₂₃H₃₅O₇.Na
      Chemical formulaC₂₃H₃₅O₇.Na
      Hygroscopic Hygroscopic
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetAMG-CoA reductase
      Primary Target K<sub>i</sub>~1 nM inhibiting 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase and blocking in vivo cholesterol synthesis
      Purity≥98% by HPLC
      Physicochemical Information
      Cell permeableN
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSQJ7185000
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Environmental Hazard
      Hazardous Materials Attention: Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
      Storage +2°C to +8°C
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      524403-25MGCN 04055977270983

      Documentation

      Pravastatin, Sodium Salt - CAS 81131-70-6 - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート（(M)SDS） 

      Pravastatin, Sodium Salt - CAS 81131-70-6 - Calbiochem 試験成績書（CoA）

      タイトルロット番号
      524403

      参考資料

      参考資料の概要
      Kwak, B., et al. 2000. Natl. Med. 6, 1399.
      Hamelin, B.A., and Turgeon, J., 1998. Trends Pharmacol. Sci. 19, 26.
      Narisawa, T., et al. 1996. Jpn. J. Cancer Res. 87, 798.
      Cohen, L.H., et al. 1993. Biochem. Pharmacol. 45, 2203.
      Koga, T., et al. 1990. Biochim. Biophys. Acta. 1045, 115.
      Yoshino, G., et al. 1986. Diabetes Res. Clin. Pract. 2, 179
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision16-May-2008 RFH
      Synonyms(βR,δR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-β,δ,6-trihydroxy-2-methyl-8[(2S)-2-methyl-1-oxobutoxyl]-1-naphthaleneheptanoic Acid Na, 3β-Hydroxycompactin, Na
      DescriptionA water-soluble, competitive 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor that blocks in vivo cholesterol synthesis (Ki ~1 nM). Also acts as an immunomodulator and an inhibitor of ras p21 isoprenylation.
      FormWhite crystalline solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number81131-70-6
      RTECSQJ7185000
      Chemical formulaC₂₃H₃₅O₇.Na
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityH₂O (100 mg/ml)
      Storage +2°C to +8°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Environmental Hazard
      Merck USA index14, 7714
      ReferencesKwak, B., et al. 2000. Natl. Med. 6, 1399.
      Hamelin, B.A., and Turgeon, J., 1998. Trends Pharmacol. Sci. 19, 26.
      Narisawa, T., et al. 1996. Jpn. J. Cancer Res. 87, 798.
      Cohen, L.H., et al. 1993. Biochem. Pharmacol. 45, 2203.
      Koga, T., et al. 1990. Biochim. Biophys. Acta. 1045, 115.
      Yoshino, G., et al. 1986. Diabetes Res. Clin. Pract. 2, 179